Edward P. Bowman

12.4k citations

50 papers · 9.8k indexed · 7 hit papers · h-index 36

Impact in

Immunology top 0.1%
- Psoriasis: Treatment and Pathogenesis
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Dermatology top 0.1%
- Dermatology and Skin Diseases

Papers in

Immunology 37
- Psoriasis: Treatment and Pathogenesis 15
- T-cell and B-cell Immunology 13
- Immunotherapy and Immune Responses 12
- Immune Cell Function and Interaction 7
Dermatology 7
- Dermatology and Skin Diseases 6

Co-authors: J. Daniel Terrill K. McClanahan Eugene C. Butcher Robert A. Kastelein Wendy M. Blumenschein René de Waal Malefyt Jason R. Chan Kathleen M. Smith
Journals: The Journal of Experimental Medicine (6 papers)Journal of Biological Chemistry (5 papers)The Journal of Immunology (4 papers)Nature Medicine (3 papers)Journal of Clinical Investigation (2 papers)
Partner nations: United States Germany Australia

In The Last Decade

Edward P. Bowman

49 papers receiving 9.5k citations

Hit Papers

7 papers align trajectories log scale

IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases 2015 · 639 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 Nature Medicine
2012 Nature Medicine
2008 The Journal of Experimental Medicine
2008 Journal of Investigative Dermatology
2007 Nature Immunology
2006 The Journal of Experimental Medicine
2002 Nature Medicine

Peers

Countries citing papers authored by Edward P. Bowman

Since Specialization

Citations

This map shows the geographic impact of Edward P. Bowman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward P. Bowman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward P. Bowman more than expected).

Fields of papers citing papers by Edward P. Bowman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward P. Bowman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward P. Bowman. The network helps show where Edward P. Bowman may publish in the future.

Co-authors

The 25 scholars most cited alongside Edward P. Bowman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Edward P. Bowman Line = papers co-authored together Edward P. Bowman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Dissociation of LAG-3 inhibitory cluster from TCR microcluster by immune checkpoint blockade Frontiers in Immunology ·Akiko Hashimoto, Edward P. Bowman, Machie Sakuma, Natsumi Yoneda, Katsuyuki Yugi, René de Waal Malefyt, Takashi Saito	2024	2
2	Antitumor efficacy of combined CTLA4/PD-1 blockade without intestinal inflammation is achieved by elimination of FcγR interactions Journal for ImmunoTherapy of Cancer ·David Bauché, Smita Mauze, Christina M. Kochel, Jeff Grein, Anandi Sawant, Yulia Zybina, Wendy M. Blumenschein, Peng Yang, Lakshmanan Annamalai, Jennifer H. Yearley, Juha Punnonen, Edward P. Bowman, Alissa A. Chackerian, Drake LaFace	2020	21
3	A capillary electrophoresis based approach for the identification of anti-drug antibodies against camelid VHH biologics (Nanobodies®) Journal of Pharmacological and Toxicological Methods ·Derek Wiswell, Divas Neupane, Minchao Chen, Edward P. Bowman, Douglas E. Linn, Anandi Sawant, Alissa A. Chackerian, Shuli Zhang, Enrique Escandón	2020	8
4	Dual Roles for Regulatory T-cell Depletion and Costimulatory Signaling in Agonistic GITR Targeting for Tumor Immunotherapy Cancer Research ·Ashley E. Mahne, Smita Mauze, Barbara Joyce-Shaikh, Jane Xia, Edward P. Bowman, Amy M. Beebe, J. Daniel, Renu Jain	2016	96
5	Clinical improvement in psoriasis with specific targeting of interleukin-23 Nature ·Tamara Kopp, Elisabeth Riedl, Christine Bangert, Edward P. Bowman, Elli K. Greisenegger, Ann D. Horowitz, Harald Kittler, Wendy M. Blumenschein, Terrill K. McClanahan, Thomas Marbury, Claus Zachariae, Danlin Xu, Xiaoli Hou, Anish Mehta, Anthe S. Zandvliet, Diana Montgomery, Frank van Aarle, Sauzanne Khalilieh	2015	165
6	Immunization withStaphylococcus aureusiron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis model Human Vaccines & Immunotherapeutics ·Amita Joshi, Greg Pancari, Leslie D. Cope, Edward P. Bowman, Daniel Cua, Richard A. Proctor, Tessie McNeely	2012	96
7	IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells Nature Medicine ·Jonathan Sherlock, Barbara Joyce-Shaikh, Scott Turner, Cheng‐Chi Chao, Manjiri Sathe, Jeff Grein, Daniel M. Gorman, Edward P. Bowman, Terrill K. McClanahan, Jennifer H. Yearley, Gérard Eberl, Christopher D. Buckley, Robert A. Kastelein, Robert H. Pierce, Drake LaFace, J. Daniel Hit paper breakdown →	2012	791
8	IL-23 Is Critical for Induction of Arthritis, Osteoclast Formation, and Maintenance of Bone Mass The Journal of Immunology ·Iannis E. Adamopoulos, Marlowe S. Tessmer, Cheng‐Chi Chao, Sarvesh Adda, Dan Gorman, Mary Petro, Chuan‐Chu Chou, Robert H. Pierce, Wei Yao, Nancy E. Lane, Drake LaFace, Edward P. Bowman	2011	158
9	Anti-IL-17A therapy protects against bone erosion in experimental models of rheumatoid arthritis Autoimmunity ·Cheng‐Chi Chao, Shi‐Juan Chen, Iannis E. Adamopoulos, Nicole L. Davis, Kyu Rak Hong, Anna Vu, Sylvia Kwan, Laurence Fayadat‐Dilman, Agelio Asio, Edward P. Bowman	2010	52
10	Myeloid DAP12-associating lectin (MDL)-1 regulates synovial inflammation and bone erosion associated with autoimmune arthritis The Journal of Experimental Medicine ·Barbara Joyce-Shaikh, Michael E. Bigler, Cheng‐Chi Chao, Erin E. Murphy, Wendy M. Blumenschein, Iannis E. Adamopoulos, Paul G. Heyworth, S. V. Antonenko, Edward P. Bowman, Terrill K. McClanahan, Joseph H. Phillips, J. Daniel	2010	75
11	Interleukin-17A upregulates receptor activator of NF-κB on osteoclast precursors Arthritis Research & Therapy ·Iannis E. Adamopoulos, Cheng-Chi Chao, Richard Geissler, Drake LaFace, Wendy M. Blumenschein, Yoichiro Iwakura, Terrill K. McClanahan, Edward P. Bowman	2010	261
12	Investigating the role of the interleukin-23/-17A axis in rheumatoid arthritis Lara D. Veeken ·Philippa Hillyer, Maggie Larché, Edward P. Bowman, Terri McClanahan, René de Waal Malefyt, Lauren P. Schewitz, Grey Giddins, M Feldmann, Rob Kastelein, Fionula M. Brennan	2009	47
13	Immune regulation of bone loss by Th17 cells Arthritis Research & Therapy ·Iannis E. Adamopoulos, Edward P. Bowman	2008	71
14	Development, cytokine profile and function of human interleukin 17–producing helper T cells Nature Immunology ·Nicholas J. Wilson, Katia Boniface, Jason R. Chan, Brent S. McKenzie, Wendy M. Blumenschein, Jeanine Mattson, Beth Basham, Kathleen M. Smith, Taiying Chen, Franck Morel, Jean‐Claude Lecron, Robert A. Kastelein, J. Daniel, Terrill K. McClanahan, Edward P. Bowman, René de Waal Malefyt Hit paper breakdown →	2007	1628
15	Regulation of Myeloid Cell Function through the CD200 Receptor The Journal of Immunology ·Maria C. Jenmalm, Holly Cherwinski, Edward P. Bowman, Joseph H. Phillips, Jonathon D. Sedgwick	2006	191
16	Rationale and safety of anti-interleukin-23 and anti-interleukin-17A therapy Current Opinion in Infectious Diseases ·Edward P. Bowman, Alissa A. Chackerian, J. Daniel	2006	47
17	CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells Journal of Clinical Investigation ·Eric J. Kunkel, Chang H. Kim, Nicole H. Lazarus, Mark A. Vierra, Dulce Soler, Edward P. Bowman, Eugene C. Butcher	2003	265
18	CCL27–CCR10 interactions regulate T cell–mediated skin inflammation Nature Medicine ·Bernhard Homey, Harri Alenius, Anja Müller, Hortensia Soto, Edward P. Bowman, Wei Yuan, Leslie M. McEvoy, Antti Lauerma, Till Assmann, Erich Bünemann, Maili Lehto, Henrik Wolff, David Yen, Heather Marxhausen, Wayne To, Jonathon D. Sedgwick, Thomas Ruzicka, Percy Lehmann, Albert Zlotnik Hit paper breakdown →	2002	592
19	Regulation of Chemotactic and Proadhesive Responses to Chemoattractant Receptors by RGS (Regulator of G-protein Signaling) Family Members Journal of Biological Chemistry ·Edward P. Bowman, James J. Campbell, Kirk M. Druey, Astrid Scheschonka, John H. Kehrl, Eugene C. Butcher	1998	111
20	Chemical Synthesis, Initial Conformational Studies, and Activity of Rat Steroidogenesis Activator Peptide and a Truncated Analog Endocrine Research ·David B. Glass, David G. Robertson, Tingsen Xu, Edward P. Bowman, J. David Lambeth	1991	1

About Edward P. Bowman

Edward P. Bowman is a scholar working on Immunology, Dermatology, Hematology, Oncology and Immunology and Allergy, having authored 50 papers that have together received 9.8k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (15 papers), T-cell and B-cell Immunology (13 papers), Immunotherapy and Immune Responses (12 papers), Immune Cell Function and Interaction (7 papers), Bone Metabolism and Diseases (7 papers), Cytokine Signaling Pathways and Interactions (6 papers), Dermatology and Skin Diseases (6 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). The work is most often cited by research in Immunology (7.0k citations), Dermatology (1.9k citations), Rheumatology (1.7k citations), Hematology (1.1k citations) and Oncology (1.8k citations). Edward P. Bowman has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include J. Daniel, Terrill K. McClanahan, Eugene C. Butcher, Robert A. Kastelein, Wendy M. Blumenschein, René de Waal Malefyt, Jason R. Chan, Kathleen M. Smith, J. David Lambeth and James G. Krueger. Their work appears in journals such as The Journal of Experimental Medicine, Journal of Biological Chemistry, The Journal of Immunology, Nature Medicine and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact